Wyeth Premarin Petition Withdrawn; Firm Hints At Future Action
Executive Summary
Wyeth is reserving its right to file future citizen petitions with regard to the manufacturing of generic Premarin (conjugated estrogens), the company says in a letter formally withdrawing a 1994 petition to block synthetically derived estrogens